Adrenocortical mitochondrial steroidogenic machinery

The adrenocortical mitochondrial membrane and its associated steroidogenic machinery constitute the primary site for the synthesis of essential steroid hormones, including cortisol and aldosterone (Miller, 2011, PMID: 21303911). This system includes the Steroidogenic Acute Regulatory (StAR) protein, which facilitates cholesterol transport into the mitochondria, and several cytochrome P450 enzymes such as CYP11A1 (cholesterol side-chain cleavage), CYP11B1 (11β-hydroxylase), and CYP11B2 (aldosterone synthase) (Miller, 2007, PMID: 17445965). These components work in concert to convert cholesterol into various steroid intermediates and final hormones. The integrity of the mitochondrial membrane is crucial for the proper functioning of these enzymes, and its disruption leads to impaired steroidogenesis and potential cell death. Pharmacological targeting of this machinery is a key strategy in treating conditions characterized by hormone excess, such as Cushing's syndrome and hyperaldosteronism, as well as in the management of adrenocortical carcinoma (Schteingart, 2007, PMID: 17634697). Drugs like mitotane exert adrenolytic effects by inducing mitochondrial damage and inhibiting enzymatic activity, while others like metyrapone and osilodrostat specifically inhibit enzymatic steps within this pathway (Pivonello et al., 2020, PMID: 32093411). Monitoring of hormone levels and adrenal function is essential when using drugs that target this machinery to avoid severe side effects like adrenal crisis. This target system remains a focus for developing more selective inhibitors to minimize off-target effects and improve patient outcomes in endocrine disorders.

Other names

Adrenal mitochondrial membraneSteroidogenic machineryMitochondrial steroidogenesis systemAdrenocortical steroidogenic enzymesMitochondrial steroidogenic complex

Inhibition of mitochondrial cytochrome P450 enzymes (CYP11A1, CYP11B1, CYP11B2) and induction of mitochondrial membrane disruption leading to adrenocortical cell death.